The company's solution to high production costs is to scale up operations -- even while making cuts elsewhere.
News & Analysis: Tilray, Inc.
The best defense during a market downturn is usually a good offense. Here are two high-growing cannabis companies that are likely to continue their momentum.
Pot stock valuations have plummeted, and these CEOs could pay the price for this underperformance.
Which one of these large-cap cannabis producers is a better buy for investors?
These three pot stocks are soaring -- unfortunately their rallies lack substance.
There are good marijuana stocks out there, but these Canadian cannabis companies have serious red flags.
The pot company's coming off a quarter where it reported a staggering loss of more than $184 million.
The cannabis company delivered better-than-expected results and got a further boost from a big state moving towards legalization.
They can blame a high-profile peer in their sector.
COVID-19 could be what seals the fates of many pot stocks this year.